TScan Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update May 7, 2025
TScan Therapeutics Announces Upcoming Presentation at the American Society of Gene and Cell Therapy 28th Annual Meeting April 30, 2025
TScan Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update March 5, 2025
TScan Therapeutics Announces $30 Million Registered Direct Offering at a 37% Premium December 27, 2024
TScan Therapeutics Named a Top Place to Work by The Boston Globe for Three Consecutive Years December 6, 2024
TScan Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update November 13, 2024
